Search Results
May 26, 2026, 08:30 ET Deepening Focus on Autoimmune Diseases, Empowering AI-Driven Drug Discovery
experimentation.HkeyBio is committed to addressing key industry pain points including translational efficiency, disease model accessibility, and R&D cost control.Comprehensive Service NetworkHkeyBio operates research facilities in Suzhou and Guangxi, with standardized laboratory
More news about: HKeyBio
May 26, 2026, 08:00 ET Citius Oncology Announces Presentation of LYMPHIR® Phase 1 Combination Study Data at the 2026 American Society of Clinical Oncology Annual Meeting
diftitox‑cxdl)INDICATIONLYMPHIR is an IL2-receptor-directed cytotoxin indicated for the treatment of adult patients with r/r Stage I-III cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.IMPORTANT SAFETY INFORMATION BOXED WARNING:
More news about: Citius Oncology, Inc.
May 26, 2026, 08:00 ET Cresset Announces The Long Game Podcast, Offering Rare Access to the Leaders Shaping the Next Century of Business
inspire actionable results. He is also past Chapter Chairman of YPO Washington Baltimore Chapter and past Tiger21 member. He is a current member of R360, Peakline, Chesapeake Spice, and Karma for Cara Foundation. Eric attended The University of Chicago and studied Economics before launching his entrepreneurial
More news about: Cresset
May 26, 2026, 07:40 ET Merach S29R2, la nueva bicicleta estática con autonomía
- Merach S29R2: La bicicleta estática con autonomía que libera a los usuarios de las suscripciones mensuales a gimnasiosLONDRES, 26 de mayo de 2026 /PRNewswire/ -- Las bicicletas estáticas conectadas suelen requerir
More news about: Merach
May 26, 2026, 07:34 ET Merach S29R2: Der Heimtrainer mit Eigenantrieb befreit die Nutzer von monatlichen Fitness-Abonnements
2026 /PRNewswire/ -- Vernetzte Fitnessbikes erfordern oft laufende monatliche Abonnements lange nach dem Kauf der Hardware, aber das neue Merach S29R2 verfolgt einen anderen Ansatz. Es kombiniert einen autarken Betrieb, einen intelligenten automatischen Widerstand und eine optionale App-Konnektivität,
More news about: Merach
May 26, 2026, 07:32 ET Merach S29R2 : Le vélo d'appartement autonome libère les utilisateurs des abonnements mensuels de fitness
Les vélos de fitness connectés nécessitent souvent des abonnements mensuels continus longtemps après l'achat du matériel, mais le nouveau Merach S29R2 adopte une approche différente. Il combine un fonctionnement auto-alimenté, une auto-résistance intelligente et une connectivité d'application optionnelle,
More news about: Merach
May 26, 2026, 07:30 ET Biohaven Reports New Clinical Data in Epilepsy with Opakalim, a Selective Kv7.2/7.3 Activator, Highlighting Seizure Control and Markedly Differentiated Tolerability Profile
Kv7.2/7.3 channel activator program, currently in Phase 2/3 studies for the treatment of focal epilepsy, and will present additional updates at its annual R&D Day held in conjunction with the Yale Innovation Summit at the Yale School of Management in New Haven, Connecticut on May 27, 2026. Opakalim is distinguished
More news about: Biohaven Ltd.
May 26, 2026, 07:27 ET Merach S29R2: samonabíjecí rotoped, který uživatele osvobozuje od měsíčního předplatného fitness služeb
2026 /PRNewswire/ -- Propojená fitness kola často vyžadují průběžné měsíční předplatné dlouho po zakoupení hardwaru, ale nový model Merach S29R2 volí odlišný přístup. Kombinuje provoz s vlastním napájením, inteligentní automatický odpor a volitelné připojení k aplikacím, včetně podpory populárních
More news about: Merach
May 26, 2026, 07:05 ET Dinto Solar Showcases Next-Generation 1/3-Cut and Vertical HJT Modules at Intersolar Europe 2026
worldwide.About Dinto SolarDinto Solar Co., Ltd. (Dinto Solar) is a China National-Level High-Tech Enterprise specializing in the R&D, manufacturing, and commercialization of ultra-high-efficiency n-type HJT solar cells and modules. Established in 2017 by the Central Research Institute
More news about: Dinto Solar
May 26, 2026, 07:03 ET THE 2026 LIVING LUXE DESIGN SHOW PRESENTED BY JENNAIR CELEBRATES A BOLD WEEKEND OF DESIGN, INNOVATION AND CULTURE
Sponsors: Epiq Vision, Tsemko Décor, Amanda Aerin, Caviar Bar & Co., Lawrence Park Development, Kanvas, Max Jamali, European Elegance, Benjamin Moore, R5 Event Design, Luméa, Cleary Canadian, Chef de la Mesa, Turfs Up, Nav's Live Pizza Palazzo, Elegance AromaThe Living Luxe Awards Show was made
More news about: Living Luxe Design Show
May 26, 2026, 06:47 ET Huawei organizuje 3. Globalny Szczyt Wizjonerów C&I, kształtując bardziej ekologiczną przyszłość dla różnych branż
DONGGUAN, Chiny, 26 maja 2026 r. /PRNewswire/ -- Huawei Digital Power zorganizował 3. Globalny Szczyt Wizjonerów C&I – czterodniowe wydarzenie obejmujące sesje Dawn i Horizon. Ponad 800 uczestników z 50 krajów analizowało
More news about: Huawei Digital Power
May 26, 2026, 05:40 ET Merach S29R2: The Self-Powered Exercise Bike Freeing Users from Monthly Fitness Subscriptions
2026 /PRNewswire/ -- Connected fitness bikes often require ongoing monthly subscriptions long after the hardware purchase, but the new Merach S29R2 takes a different approach. It combines self-powered operation, smart auto-resistance, and optional app connectivity, including support for popular
More news about: Merach
May 26, 2026, 05:15 ET ELBIT SYSTEMS REPORTS FIRST QUARTER 2026 RESULTS
robotics and AI, while maintaining strict capital discipline and expanding operational margins. At the same time, we are increasing our investment in R&D and innovation to shape the Company's next-generation offering and strengthen our long-term growth platform."First quarter 2026 results:Revenues
More news about: Elbit Systems Ltd.
May 26, 2026, 05:00 ET Yatsen Announces First Quarter 2026 Financial Results
year-over-year growth of 58.5%. Guided by our vision to become a world-class pioneer in beauty innovation, we remain committed to strengthening our R&D-led innovation, expanding our hero product families, and positioning our core brands for high-quality growth. Furthermore, we are pleased to note that
More news about: Yatsen Holding Limited
May 26, 2026, 04:23 ET RHINOSHIELD AirX reçoit deux distinctions mondiales pour son design : 2026 iF Design Award × Red Dot Design Award
utilisateurs sur des marchés multilingues dans plus de 9 langues et protégeant plus de 20 millions d'appareils dans le monde entier.Avec une R&D et une fabrication intégrées à Taiwan, RHINOSHIELD fait progresser l'innovation en matière de matériaux grâce à des solutions de conception circulaire
More news about: RHINOSHIELD
May 26, 2026, 03:29 ET Scania pioneers vehicle-to-grid through Megawatt Charging System for heavy transport
https://news.cision.com/scania/r/scania-pioneers-vehicle-to-grid-through-megawatt-charging-system-for-heavy-transport,c4352670The following files are available for download:
More news about: Scania
May 26, 2026, 03:18 ET RHINOSHIELD AirX Earns Double Global Design Honors: 2026 iF Design Award × Red Dot Design Award
footprint, engaging users across multilingual markets in over 9 languages and protecting over 20 million devices worldwide.With integrated R&D and manufacturing in Taiwan, RHINOSHIELD advances material innovation through circular design and plastic management solutions—creating high-performance
More news about: RHINOSHIELD
May 26, 2026, 02:52 ET From hair dryers to global shipping routes: A quick look at Ningbo's manufacturing network
brands.Starting with its first self-developed curved range hood in 1996, Fotile began building its own core technologies through independent R&D. "Today, Fotile products have entered major US retail chains including Lowe's, while continuing to expand in markets including Malaysia and Indonesia,"
More news about: Global Times
May 26, 2026, 02:45 ET Astellas Announces Five-Year Corporate Strategic Plan to Deliver Greater VALUE Faster for Patients and Position Itself as a Sustainable Growth Company
in core OP before R&D expenses over the CSP2026 period, providing a strong internal funding base for its strategy. The company will transform its cost structure, maintaining 50 percent core operating profit before R&D investment, which will allow flexibility to increase R&D investment as the
More news about: Astellas Pharma Inc.
May 26, 2026, 02:33 ET Betolar introduces a new drone protection solution for large-scale critical infrastructure facilities
https://news.cision.com/betolar-oyj/r/betolar-introduces-a-new-drone-protection-solution-for-large-scale-critical-infrastructure-facilitie,c4352989
More news about: Betolar Oyj
May 26, 2026, 02:27 ET Lundbeck receives marketing authorization for Vyepti® (eptinezumab) in South Korea for the preventive treatment of migraine
https://news.cision.com/h--lundbeck-a-s/r/lundbeck-receives-marketing-authorization-for-vyepti---eptinezumab--in-south-korea-for-the-preventiv,c4352361The following files are available for download:
More news about: H. Lundbeck A/S
May 26, 2026, 02:24 ET Netlight expandiert nach Wien - Stärkung der Position in der DACH-Region
https://news.cision.com/de/netlight-consulting-ab/r/netlight-expandiert-nach-wien---starkung-der-position-in-der-dach-region,c4352868Für folgende Dateien besteht die Möglichkeit eines Download:
More news about: Netlight Consulting AB
May 26, 2026, 00:35 ET Over 40 Studies Featuring Akeso's Innovative Oncology Agents to Be Presented at ASCO 2026: Ivonescimab's HARMONi-6 Overall Survival Data Selected for Plenary Session
best-in-class innovative biological medicines. Founded in 2012, the company has established a robust R&D innovation ecosystem centered on its Tetrabody antibody technology platform, AI-powered drug R&D platform, Dual-Shield ADC technology platform, Dual-Lock T-cell engager (TCE) technology platform,
More news about: Akeso, Inc.
May 25, 2026, 22:53 ET Hansa Biopharma Announces Late-Breaking Abstract from ConfIdeS Phase 3 Trial Selected for Oral Presentation at ATC 2026
Across High-strength Donor-specific Antibody. Ann Surg. 2018 Sep;268(3):488-496. doi: 10.1097/ Alelign T, Ahmed MM, Bobosha K, Tadesse Y, Howe R, Petros B. Kidney Transplantation: The Challenge of Human Leukocyte Antigen and Its Therapeutic Strategies. J Immunol Res. 2018 Mar 5;2018:5986740. Available
More news about: Hansa Biopharma AB